Ambalal Sarabhai Enterprises Overview
Fundamentals of Ambalal Sarabhai Enterprises
|P/E Ratio (TTM)||60.05|
|Debt to Equity||0.32|
Financials of Ambalal Sarabhai Enterprises
|Sep 2022||Dec 2022||Mar 2023||Jun 2023|
|Profit before tax||2.04||3.45||6.93||-4.6|
|EPS in Rs||0.13||0.4||0.72||-0.64|
About Ambalal Sarabhai Enterprises
Ambalal Sarabhai Enterprises Ltd produces a range of bulk drugs, pharmaceutical preparations and electronic instruments. The company operates in two segments, namely pharmaceuticals and electronics. P ... harmaceuticals segment is engaged in manufacture of drugs and formulations. Electronics segment is engaged in manufacture of electronics instruments and services. Their subsidiaries include Synbiotics Ltd, Haryana Containers Ltd, Asence Inc, Asence Pharma Pvt Ltd, Mautik Exim Ltd, Systronics ( I ) Ltd, Suvik Hitek Pvt Ltd and Vovanties Lab Pvt Ltd. Ambalal Sarabhai Enterprises Ltd was incorporated on June 5, 1978. The company became a public limited company in December 1980. In the year 1994, the company entered into a technical collaboration with Biobras, Brazil, to manufacture highly purified insulin injections. During the year 1997-98, the company formed a joint venture company, namely Sarabhai Piramal Pharmaceuticals Ltd with Piramal Enterprises Ltd for marketing of certain products under trademarks being used by the company. During the year 1998-99, the company signed agreement with B V Chiron, Netherlands for introducing their anti-cancer drugs in India. During the year 1999-2000, the company entered into an MoU for marketing of products of Oncology products of Chiron Corporation, USA. The product division essentially comprising of Sarabai Chemicals products was transferred to the joint venture company, Sarabhai Piramal Pharmaceuticals Ltd. In September 2008, the company acquired the manufacturing and marketing company, namely Suvik Hitek Pvt. Ltd. The Ethical Division re-launched the products of Suvik and Sarabhai Chemicals in market. Also, the company acquired Systronics (India) Pvt Ltd. During the year 2008-09, the Oncology Division launched two new products viz. Fludagem & Xtinib. Also, the company promoted a company viz. Vovanties Laboratories Pvt Ltd, a pharmaceutical specialist with a vision to establish a state of the art manufacturing facility specializing in Novel Effervescent drug delivery system. During the year 2010-11, the company has transferred and assigned as a going concern the undertaking and business of Sarabhai Chemicals Bulk Drug Division to Synbiotics Ltd and electronics division comprising of Systronics, Teleradand SERC to Systronics (India) Ltd with effect from October 01, 2010. Read More
|Stocks||Market Cap (cr)||Market Price (₹)||52 Week Low-High (₹)|
|Supriya Lifescience Ltd||₹2,230.98||
|275.25 - 283.75|
|Celestial Biolabs Ltd||₹4.56||
|1.75 - 1.8|
|JFL Life Sciences Ltd||₹49.77||
|44 - 47.85|
|Procter & Gamble Health Ltd||₹8,069.18||
|4850.05 - 4977|
|Veerhealth Care Ltd||₹43.30||
|26 - 26|
What is the Share price of Ambalal Sarabhai Enterprises (AMBASARABH)?
Can I buy Ambalal Sarabhai Enterprises (AMBASARABH) shares?
How do I buy Ambalal Sarabhai Enterprises (AMBASARABH) from Angel One?
- Direct investment: You can buy Ambalal Sarabhai Enterprises (AMBASARABH) shares by opening a Demat account with Angel One.
- Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Ambalal Sarabhai Enterprises (AMBASARABH) shares.